US 11124493
Nuclear transport modulators and uses thereof
granted A61PA61P11/00A61P17/02
Quick answer
US patent 11124493 (Nuclear transport modulators and uses thereof) held by Karyopharm Therapeutics Inc. expires Mon Sep 16 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Karyopharm Therapeutics Inc.
- Grant date
- Tue Sep 21 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 16 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 10
- CPC classes
- A61P, A61P11/00, A61P17/02, A61P25/00, A61P25/28